Mfluidx, Inc
Advertisement
mFluiDx, Inc., based in Oakland, California, is a pioneering company focused on developing the SIMPLECHIP, a point-of-care molecular test that offers PCR-equivalent results at a cost comparable to rapid antigen tests. This innovative technology enables rapid, decentralized screening for multiple pathogens in small clinics and pharmacies, significantly enhancing accessibility to diagnostic testing.
Utilizing low-cost microfluidics, mFluiDx's platform allows for multitarget testing from a single disposable cartridge, ensuring high sensitivity and specificity through automated sample-to-answer processes. The company has garnered recognition as a TechCrunch Battlefield finalist and has received funding from prestigious organizations, including the Gates Foundation and NIH, underscoring its potential impact in the field of molecular diagnostics.
Generated from the website
Also at this address
You might also like
Partial Data by Infogroup (c) 2025. All rights reserved.
Advertisement

